title: A quantitative analysis of Ureaplasma urealyticum and Ureaplasma parvum compared with host immune response in preterm neonates at risk of developing bronchopulmonary dysplasia.
abstract: Multiplex, real-time PCR for the identification of Ureaplasma urealyticum and Ureaplasma parvum was performed on nucleic acids extracted from sequential endotracheal aspirates obtained from preterm neonates born at <29 weeks of gestation and ventilated for more than 48 h admitted to two level 3 neonatal intensive care units. Specimens were obtained shortly after birth and sequentially up until extubation. One hundred fifty-two specimens (93.8%) contained material suitable for analysis. Ureaplasma spp. were identified in 5 of 13 neonates studied. In most cases, the DNA load of the detected Ureaplasma species was low and decreased over time. In addition, changes in detectable Ureaplasma species DNA did not relate to changes in the inflammatory marker C-reactive protein (CRP) or respiratory status. All but two blood samples obtained at times of suspected sepsis were culture positive for other microorganisms; the species cultured were typically coagulase-negative staphylococci and were associated with increased levels of CRP (>10 mg/liter). This study was limited by the small number of patients examined and does not have the power to support or contradict the hypothesis that postnatal lung infection with Ureaplasma parvum is causally related to bronchopulmonary dysplasia (BPD) or adverse respiratory outcomes after preterm birth. However, in this study, increases in CRP levels were not associated with patients in whom Ureaplasma parvum was detected, in contrast to the detection of other bacterial species.
authors.affiliation: Institute of Pharmaceutical Sciences, King’s College London, London, UK.
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Payne
authors.forename: Kevin C W
authors.initials: KC
authors.lastname: Goss
authors.forename: Gary J
authors.initials: GJ
authors.lastname: Connett
authors.forename: Julian P
authors.initials: JP
authors.lastname: Legg
authors.forename: Ken D
authors.initials: KD
authors.lastname: Bruce
authors.forename: Vicki
authors.initials: V
authors.lastname: Chalker
mesh_terms: D058491:Bacterial Load; D001997:Bronchopulmonary Dysplasia / Q000209:etiology / Q000276:immunology / Q000382:microbiology* / Q000473:pathology; D002097:C-Reactive Protein / Q000032:analysis; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D060885:Multiplex Polymerase Chain Reaction / Q000379:methods; D047928:Premature Birth; D012121:Respiration, Artificial / Q000009:adverse effects; D014509:Ureaplasma / Q000276:immunology / Q000302:isolation & purification*; D016869:Ureaplasma Infections / Q000276:immunology / Q000382:microbiology* / Q000473:pathology; D016990:Ureaplasma urealyticum / Q000276:immunology / Q000302:isolation & purification*
chemical_list: D002097:C-Reactive Protein